Determinants of Bone Strength Estimated by Calcaneal Ultrasonography in Inuit Women from Nuuk (Greenland)
Table 1
Characteristics of Inuit women.
2002 measurements (8)
Mean ± SD
Range
SOS (m/s)
1468–1600
BUA (dB/MHz)
80–144
SI (%)
50–124
2000 measurements
Participation in 2000 and 2002 ()
Nonparticipation in 2002 ()
Comparison
QUS parameters
Mean ± SD
Mean ± SD
Student’s -test valuea
Range
Range
SOS (m/s)
0.7479
1464–1595
1463–1592
BUA (dB/MHz)
0.8703
84–136
82–140
SI (%)
0.9319
51–117
47–116
Other factors
Age (years)
0.3261
49–64
49–63
Total breastfeeding duration (months)
0.3797
0–216
1–108
Height (cm)
0.7810
142–171
145–171
Body weight (kg)
0.7164
37–99
36–99
Ratio abdominal/hip circumference
0.2672
0.78–1.09
0.77–1.10
Total cholesterol (mmol/L)
0.6783
1.73–4.67
1.38–4.24
Total triglycerides (mmol/L)
0.5939
0.44–13.36
0.61–3.87
Omega-3 PUFA (%)
0.8476
4.78–27.56
6.15–25.18
Omega-6 PUFA (%)
0.5106
12.44–31.45
10.87–29.55
Ratio omega-3/omega-6 PUFA
0.7657
0.17–2.21
0.21–2.32
DL-PCB 156 (μg/L)
0.1450
0.13–2.12
0.22–2.31
0.62b
0.72b
(%)
(%)
valuea
Menopausal status
118
30
0.5062c
Postmenopausal
107 (90.7)
26 (86.7)
Nonmenopausal
11 (9.3)
4 (13.3)
Parity
118
30
0.2139c
Yes
108 (91.5)
30 (100)
No
10 (8.5)
0 (0)
Personal history of fracture
118
30
0.3002c
Yes
9 (7.6)
4 (13.3)
No
109 (92.4)
26 (86.7)
Causes of secondary osteoporosis (CSO)
118
30
1.0000c
Yes
12 (10.2)
3 (10)
No
106 (89.8)
27 (90)
Calcium supplement use
118
30
0.4679c
Yes
12 (10.2)
1 (3.3)
No
106 (89.8)
29 (96.7)
HRT use
118
30
0.7272c
Yes
10 (8.5)
3 (10)
No
108 (91.5)
27 (90)
Oral contraceptive use
118
30
0.9865d
Yes
47 (39.8)
12 (40)
No
71 (60.2)
18 (60)
Leisure physical activity (LPA)
118
30
0.7415c
Active
12 (10.2)
4 (13.3)
Inactive or little activity
106 (89.8)
26 (86.7)
Smoking status
118
30
0.2059d
Yes
85 (72)
25 (83.3)
No
33 (28)
5 (16.7)
Sun exposure
118
30
0.7987d
Yes
25 (21.2)
7 (23.3)
No
93 (78.8)
23 (76.7)
Alcohol intake
118
30
0.6026d
Yes
73 (61.9)
17 (56.7)
No
45 (38.1)
13 (43.3)
Consumption of dairy products
118
30
1.0000c
Yes (≥1/jour)
106 (89.8)
27 (90)
No (0/jour)
12 (10.2)
3 (10)
Comparison between the participants () and the nonparticipants () to the second QUS measurement (2002); bGeometric mean; cFisher’s exact test; dChi square test.